The daily business briefing: July 12, 2022

Twitter calls Musk effort to scrap deal "wrongful," HRA Pharma asks FDA to approve birth-control pill sales over the counter, and more

Elon Musk
(Image credit: Chris Delmas/AFP via Getty Images)

1. Twitter calls Musk move to end purchase deal 'invalid and wrongful'

Twitter on Monday called Tesla CEO Elon Musk's effort to call off his $44 billion deal to buy the social-media giant "invalid and wrongful." Musk accuses Twitter of failing to deliver adequate information on what percentage of its accounts are fake, but Twitter says it has provided ample data. "Twitter has breached none of its obligations under the agreement, and Twitter has not suffered and is not likely to suffer a company material adverse effect," Twitter's lawyers wrote in a regulatory filing Monday. An attorney for Musk declined to comment to The Wall Street Journal. Legal experts have said that they expect an expensive court battle if Musk doesn't go through with the deal.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.